88 related articles for article (PubMed ID: 21912780)
1. A general synthesis of dirhodium metallopeptides as MDM2 ligands.
Zaykov AN; Ball ZT
Chem Commun (Camb); 2011 Oct; 47(39):10927-9. PubMed ID: 21912780
[TBL] [Abstract][Full Text] [Related]
2. Helix induction by dirhodium: access to biocompatible metallopeptides with defined secondary structure.
Zaykov AN; Popp BV; Ball ZT
Chemistry; 2010 Jun; 16(22):6651-9. PubMed ID: 20411535
[TBL] [Abstract][Full Text] [Related]
3. Structure-selective modification of aromatic side chains with dirhodium metallopeptide catalysts.
Popp BV; Ball ZT
J Am Chem Soc; 2010 May; 132(19):6660-2. PubMed ID: 20420453
[TBL] [Abstract][Full Text] [Related]
4. Site-specific protein modification with a dirhodium metallopeptide catalyst.
Chen Z; Popp BV; Bovet CL; Ball ZT
ACS Chem Biol; 2011 Sep; 6(9):920-5. PubMed ID: 21671614
[TBL] [Abstract][Full Text] [Related]
5. Catalytic protein modification with dirhodium metallopeptides: specificity in designed and natural systems.
Chen Z; Vohidov F; Coughlin JM; Stagg LJ; Arold ST; Ladbury JE; Ball ZT
J Am Chem Soc; 2012 Jun; 134(24):10138-45. PubMed ID: 22621321
[TBL] [Abstract][Full Text] [Related]
6. A robust strategy for the preparation of libraries of metallopeptides. A new paradigm for the discovery of targeted molecular imaging and therapy agents.
Armstrong AF; Oakley N; Parker S; Causey PW; Lemon J; Capretta A; Zimmerman C; Joyal J; Appoh F; Zubieta J; Babich JW; Singh G; Valliant JF
Chem Commun (Camb); 2008 Nov; (43):5532-4. PubMed ID: 18997942
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
[TBL] [Abstract][Full Text] [Related]
8. Studies of asymmetric styrene cyclopropanation with a rhodium(II) metallopeptide catalyst developed with a high-throughput screen.
Sambasivan R; Ball ZT
Chirality; 2013 Sep; 25(9):493-7. PubMed ID: 23749505
[TBL] [Abstract][Full Text] [Related]
9. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Shin JS; Ha JH; Chi SW
Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
[TBL] [Abstract][Full Text] [Related]
10. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
[TBL] [Abstract][Full Text] [Related]
11. Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.
Dastidar SG; Lane DP; Verma CS
J Am Chem Soc; 2008 Oct; 130(41):13514-5. PubMed ID: 18800837
[TBL] [Abstract][Full Text] [Related]
12. Sequence-specific inhibition of a designed metallopeptide catalyst.
Popp BV; Chen Z; Ball ZT
Chem Commun (Camb); 2012 Aug; 48(60):7492-4. PubMed ID: 22728748
[TBL] [Abstract][Full Text] [Related]
13. Miniature protein inhibitors of the p53-hDM2 interaction.
Kritzer JA; Zutshi R; Cheah M; Ran FA; Webman R; Wongjirad TM; Schepartz A
Chembiochem; 2006 Jan; 7(1):29-31. PubMed ID: 16397877
[No Abstract] [Full Text] [Related]
14. Molecular Simulations Identify Binding Poses and Approximate Affinities of Stapled α-Helical Peptides to MDM2 and MDMX.
Morrone JA; Perez A; Deng Q; Ha SN; Holloway MK; Sawyer TK; Sherborne BS; Brown FK; Dill KA
J Chem Theory Comput; 2017 Feb; 13(2):863-869. PubMed ID: 28042965
[TBL] [Abstract][Full Text] [Related]
15. Designing Selectivity in Dirhodium Metallopeptide Catalysts for Protein Modification.
Martin SC; Vohidov F; Wang H; Knudsen SE; Marzec AA; Ball ZT
Bioconjug Chem; 2017 Feb; 28(2):659-665. PubMed ID: 28035818
[TBL] [Abstract][Full Text] [Related]
16. Metallopeptides for asymmetric dirhodium catalysis.
Sambasivan R; Ball ZT
J Am Chem Soc; 2010 Jul; 132(27):9289-91. PubMed ID: 20518468
[TBL] [Abstract][Full Text] [Related]
17. Structure of the stapled p53 peptide bound to Mdm2.
Baek S; Kutchukian PS; Verdine GL; Huber R; Holak TA; Lee KW; Popowicz GM
J Am Chem Soc; 2012 Jan; 134(1):103-6. PubMed ID: 22148351
[TBL] [Abstract][Full Text] [Related]
18. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
Qin L; Yang F; Zhou C; Chen Y; Zhang H; Su Z
J Am Chem Soc; 2014 Dec; 136(52):18023-33. PubMed ID: 25453499
[TBL] [Abstract][Full Text] [Related]
19. De novo designed library of linear helical peptides: an exploratory tool in the discovery of protein-protein interaction modulators.
Bonache MÁ; Balsera B; López-Méndez B; Millet O; Brancaccio D; Gómez-Monterrey I; Carotenuto A; Pavone LM; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; de la Torre-Martinez R; Fernández-Carvajal A; Ferrer-Montiel A; García-López MT; Martín-Martínez M; de Vega MJ; González-Muñiz R
ACS Comb Sci; 2014 May; 16(5):250-8. PubMed ID: 24725184
[TBL] [Abstract][Full Text] [Related]
20. Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.
Burch L; Shimizu H; Smith A; Patterson C; Hupp TR
J Mol Biol; 2004 Mar; 337(1):129-45. PubMed ID: 15001357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
